Management of children with congenital heart defect: state of the art and future prospects.

[en] The treatment of children with congenital heart defects has evolved in the last 60 years from conservative care to a highly specialized management where advances in imaging, surgical, interventional and support techniques meet together to ensure satisfactory development and good quality of life to the child and to the upcoming grown up. Management of congenital heart defects best begins before birth with the aim, whenever possible, to maintain or establish biventricular physiology or, if this is excluded, to optimize the conditions for univentricular physiology. Current research in the field of genetics, device bioengineering and miniaturization, stem cell therapy, and fusion imaging technology is expected to help to improve further patient outcome. In this review, current management strategies and future prospects are discussed.

Disciplines :

Cardiovascular & respiratory systems
Pediatrics

Author, co-author :

Seghaye, Marie-Christine ; Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie cardiologique et pneumologique

Language :

English

Title :

Management of children with congenital heart defect: state of the art and future prospects.

Publication date :

January 2017

Journal title :

Future Cardiology

ISSN :

1479-6678

eISSN :

1744-8298

Publisher :

Future Medicine, United Kingdom

Volume :

Issue :

Pages :

65-79

Peer reviewed :

Peer reviewed

Available on ORBi :

since 10 November 2017

Statistics

Number of views

64 (5 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Khairy P, Ionescu-Ittu R, Mackie AS et al. Changing mortality in congenital heart disease. J. Am. Coll. Cardiol. 56, 1149-1157 (2010).
Baumgartner H, Bonhoeffer P, De Groot NM et al. ESC guidelines for the management of grown-up congenital heart disease. Eur. Heart J. 31, 2915-2957 (2010).
Donofrio MT, Moon-Grady AJ, Hornberger LK et al. Diagnosis and treatment of fetal cardiac disease. Circulation 129, 2183-2242 (2014).
Quarello E, Lafouge A, Fries N et al. BASIC HEART: a feasibility study of first-trimester systematic simplified fetal echocardiography. Ultrasound Obstet. Gynecol. doi:10.1002/ uog.15866 (2016) (Epub ahead of print).
Sharland G. Fetal cardiac screening: why bother? Arch. Dis. Child Fetal Neonatal Ed. 95, F64-F68 (2010).
Carvalho JS. Antenatal diagnosis of critical congenital heart disease. Optimal place of delivery is where appropriate care can be delivered. Arch. Dis. Child. 101, 505-507 (2016).
Eckersley LSL, Parry E, Finucane K et al. Timing of diagnosis affects mortality in critical congenital heart disease. Arch. Dis. Child. 101, 516-520 (2016).
Freud LR, Tworetzky W. Fetal interventions for congenital heart disease. Curr. Opin. Pediatr. 28, 156-162 (2016).
Qing M, Schumacher K, Heise R et al. Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects. J. Am. Coll. Cardiol. 41, 2266-2274 (2003).
Heying R, Qing M, Schumacher K et al. Myocardial cardiotrophin-1 is differentially induced in congenital cardiac defects depending on hypoxemia. Future Cardiol. 10, 53-62 (2014).
Liersch PN, Schwarz A, Sachweh J et al. Gene expression of cytokines, growth factors and apoptosis regulators in a neonatal model of pulmonary stenosis. Future Cardiol. 11, 297-307 (2015).
Weber KT, Sun Y, Bhattacharya SK et al. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 10, 15-26 (2013).
Wilkins MR. Pulmonary hypertension: the science behind the disease spectrum. Eur. Respir. Rev. 21, 19-26 (2012).
Gatzoulis MA, Alonso-Gonzalez R, Beghetti M. Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease. Eur. Respir. Rev. 18, 154-161 (2009).
Haworth SG. The management of pulmonary hypertension in children. Arch. Dis. Child. 93, 620-625 (2008).
Myers PO, Tissot C, Beghetti M. Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease. Circ. J. 78, 4-11 (2014).
Abman SH, Hansmann G, Archer SL et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation 132, 2037-2099 (2015).
Gewillig M. The Fontan circulation. Heart 91, 839-846 (2005).
Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation 115, 800-812 (2007).
Sano S, Ishino K, Kawada M et al. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J. Thorac. Cardiovasc. Surg. 126, 504-509; discussion 509-510 (2003).
Bautista-Hernandez V, Karamanlidis G, McCully JD et al. Cellular and molecular mechanisms of low cardiac output syndrome after pediatric cardiac surgery. Curr. Vasc. Pharmacol. 14, 5-13 (2016).
Haworth SG, Hislop AA. Adaptation of the pulmonary circulation to extra-uterine life in the pig and its relevance to the human infant. Cardiovasc. Res. 15, 108-119 (1981).
Hinton M, Mellow L, Halayko AJ et al. Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L375-L384 (2006).
Jacobs JP, O'Brien SM, Pasquali SK et al. The Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model: part 2-clinical application. Ann. Thorac. Surg. 100, 1063-1068; discussion 1068-1070 (2015).
Arnold PD. Coagulation and the surgical neonate. Paediatr. Anaesth. 24, 89-97 (2014).
Heying R, Wehage E, Schumacher K et al. Dexamethasone pretreatment provides antiinflammatory and myocardial protection in neonatal arterial switch operation. Ann. Thorac. Surg. 93, 869-876 (2012).
Piggott KD, Soni M, Decampli WM et al. Acute kidney injury and fluid overload in neonates following surgery for congenital heart disease. World J. Pediatr. Congenit. Heart Surg. 6, 401-406 (2015).
Seghaye MC, Duchateau J, Grabitz RG et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J. Thorac. Cardiovasc. Surg. 112, 687-697 (1996).
McMahon CK, Klein I, Ojamaa K. Interleukin-6 and thyroid hormone metabolism in pediatric cardiac surgery patients. Thyroid 13, 301-304 (2003).
Hovels-Gurich HH, Seghaye MC, Sigler M et al. Neurodevelopmental outcome related to cerebral risk factors in children after neonatal arterial switch operation. Ann. Thorac. Surg. 71, 881-888 (2001).
Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc. Biol. Sci. 282, 20143085 (2015).
Meisner H. Milestones in surgery: 60 years of open heart surgery. Thorac. Cardiovasc. Surg. 62, 645-650 (2014).
Jonas RA. Comprehensive Surgical Management of Congenital Heart Disease (2nd Edition). CRC Press, London, UK (2014).
Dipchand AI, Kirk R, Edwards LB et al. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official pediatric heart transplantation report - 2013; focus theme: age. J. Heart Lung Transplant. 32, 979-988 (2013).
Jacobs JP, Mavroudis C, Quintessenza JA et al. Reoperations for pediatric and congenital heart disease: an analysis of the Society of Thoracic Surgeons (STS) congenital heart surgery database. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 17, 2-8 (2014).
Feinstein JA, Benson DW, Dubin AM et al. Hypoplastic left heart syndrome: current considerations and expectations. J. Am. Coll. Cardiol. 59, S1-S42 (2012).
Hibino N, He D, Yuan F et al. Growth of diminutive central pulmonary arteries after right ventricle to pulmonary artery homograft implantation. Ann. Thorac. Surg. 97, 2129-2133 (2014).
Nelson JS, Pasquali SK, Pratt CN et al. Long-term survival and reintervention after the Ross procedure across the pediatric age spectrum. Ann. Thorac. Surg. 99, 2086-2094; discussion 2094-2085 (2015).
Seghaye MC, Duchateau J, Grabitz RG et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J. Thorac. Cardiovasc. Surg. 106, 978-987 (1993).
Seghaye MC. The clinical implications of the systemic inflammatory reaction related to cardiac operations in children. Cardiol. Young 13, 228-239 (2003).
Hövels-Gürich HH, Konrad K, Skorzenski D et al. Long-term behavior and quality of life after corrective cardiac surgery in infancy for tetralogy of Fallot or ventricular septal defect. Pediatr. Cardiol. 28(5), 346-354 (2007).
Gaynor JW, Stopp C, Wypij D et al. Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics 135, 816-825 (2015).
Chandler HK, Kirsch R. Management of the low cardiac output syndrome following surgery for congenital heart disease. Curr. Cardiol. Rev. 12, 107-111 (2016).
Ferrer-Barba A, Gonzalez-Rivera I, Bautista-Hernandez V. Inodilators in the management of low cardiac output syndrome after pediatric cardiac surgery. Curr. Vasc. Pharmacol. 14, 48-57 (2016).
Avila-Alvarez A, Del Cerro Marin MJ, Bautista-Hernandez V. Pulmonary vasodilators in the management of low cardiac output syndrome after pediatric cardiac surgery. Curr. Vasc. Pharmacol. 14, 37-47 (2016).
Alten JA, Borasino S, Toms R et al. Early initiation of arginine vasopressin infusion in neonates after complex cardiac surgery. Pediatr. Crit. Care Med. 13, 300-304 (2012).
Robert SM, Borasino S, Dabal RJ et al. Postoperative hydrocortisone infusion reduces the prevalence of low cardiac output syndrome after neonatal cardiopulmonary bypass. Pediatr. Crit. Care Med. 16, 629-636 (2015).
Riley AA, Jefferies JL, Nelson DP et al. Peritoneal dialysis does not adversely affect kidney function recovery after congenital heart surgery. Int. J. Artif. Organs 37, 39-47 (2014).
Santiago MJ, Lopez-Herce J, Urbano J et al. Continuous renal replacement therapy in children after cardiac surgery. J. Thorac. Cardiovasc. Surg. 146, 448-454 (2013).
Misfeldt AM, Kirsch RE, Goldberg DJ et al. Outcomes of single-ventricle patients supported with extracorporeal membrane oxygenation. Pediatr. Crit. Care Med. 17, 194-202 (2016).
Steffen RJ, Miletic KG, Schraufnagel DP et al. Mechanical circulatory support in pediatrics. Expert Rev. Med. Devices 13(5), 507-514 (2016).
Hijazi ZM, Awad SM. Pediatric cardiac interventions. JACC Cardiovasc. Interv. 1, 603-611 (2008).
Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries. JAMA 196, 991-992 (1966).
Boehm W, Emmel M, Sreeram N. Balloon atrial septostomy: history and technique. Images Paediatr. Cardiol. 8, 8-14 (2006).
Leonard GT Jr, Justino H, Carlson KM et al. Atrial septal stent implant: atrial septal defect creation in the management of complex congenital heart defects in infants. Congenit. Heart Dis. 1, 129-135 (2006).
Bonhoeffer P, Boudjemline Y, Saliba Z et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 356, 1403-1405 (2000).
Cullen MW, Cabalka AK, Alli OO et al. Transvenous, antegrade melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. JACC Cardiovasc. Interv. 6, 598-605 (2013).
Ashfaq M, Houston AB, Gnanapragasam JP et al. Balloon atrial septostomy under echocardiographic control: six years' experience and evaluation of the practicability of cannulation via the umbilical vein. Br. Heart J. 65, 148-151 (1991).
Justino H, Petit CJ. Percutaneous common carotid artery access for pediatric interventional cardiac catheterization. Circ. Cardiovasc. Interv. 9, e003003 (2016).
Shim D, Lloyd TR, Cho KJ et al. Transhepatic cardiac catheterization in children. Evaluation of efficacy and safety. Circulation 92, 1526-1530 (1995).
Hascoet S, Warin-Fresse K, Baruteau AE et al. Cardiac imaging of congenital heart diseases during interventional procedures continues to evolve: Pros and cons of the main techniques. Arch. Cardiovasc. Dis. 109, 128-142 (2016).
Schranz D, Michel-Behnke I, Heyer R et al. Stent implantation of the arterial duct in newborns with a truly duct-dependent pulmonary circulation: a single-center experience with emphasis on aspects of the interventional technique. J. Interv. Cardiol. 23, 581-588 (2010).
Siddiqui J, Brizard CP, Galati JC et al. Surgical valvotomy and repair for neonatal and infant congenital aortic stenosis achieves better results than interventional catheterization. J. Am. Coll. Cardiol. 62, 2134-2140 (2013).
Fiore AC, Fischer LK, Schwartz T et al. Comparison of angioplasty and surgery for neonatal aortic coarctation. Ann. Thorac. Surg. 80, 1659-1664; discussion 1664-1655 (2005).
Du ZD, Hijazi ZM, Kleinman CS et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll. Cardiol. 39, 1836-1844 (2002).
Dittrich S, Sigler M, Priessmann H. Late complete atrioventricular block after closure of an atrial septal defect with a gore septal occluder (GSO). Catheter Cardiovasc. Interv. 87, 945-950 (2016).
Vogt MO, Kuhn A, Horer J et al. Clinical, echocardiographic and histopathologic findings in nine patients with surgically explanted ASD/PFO devices: do we know enough about the healing process in humans? Int. J. Cardiol. 147, 398-404 (2011).
Backes CH, Cheatham SL, Deyo GM et al. Percutaneous patent ductus arteriosus (PDA) closure in very preterm infants: feasibility and complications. J. Am. Heart Assoc. doi:10.1161/JAHA.115.002923 (2016) (Epub ahead of print).
Rao PS. Percutaneous balloon pulmonary valvuloplasty: state of the art. Catheter Cardiovasc. Interv. 69, 747-763 (2007).
Khambadkone S. Percutaneous pulmonary valve implantation. Ann. Pediatr. Cardiol. 5, 53-60 (2012).
Gurvitch R, Cheung A, Ye J et al. Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J. Am. Coll. Cardiol. 58, 2196-2209 (2011).
Hill SL, Hijazi ZM, Hellenbrand WE et al. Evaluation of the AMPLATZER vascular plug for embolization of peripheral vascular malformations associated with congenital heart disease. Catheter Cardiovasc. Interv. 67, 113-119 (2006).
Seghaye MC, Wainwright U, von Bermuth G. Use of an Amplatzer ductal occluder to close a persistent left superior caval vein which reopened after a total cavopulmonary anastomosis. Cardiol. Young 12, 81-83 (2002).
Postma AV, Bezzina CR, Christoffels VM. Genetics of congenital heart disease: the contribution of the noncoding regulatory genome. J. Hum. Genet. 61, 13-19 (2016).
Heydrick S, Roberts E, Kim J et al. Pediatric cardiovascular grafts: historical perspective and future directions. Curr. Opin. Biotechnol. 40, 119-124 (2016).
Salinas M, Rath S, Villegas A et al. Relative effects of fluid oscillations and nutrient transport in the in vitro growth of valvular tissues. Cardiovasc. Eng. Technol. 7, 170-181 (2016).
Flanagan TC, Cornelissen C, Koch S et al. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 28, 3388-3397 (2007).
Hof A, Raschke S, Baier K et al. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis. Eur. J. Cardiothorac. Surg. 50(3), 446-455 (2016).
Reimer J, Syedain Z, Haynie B et al. Implantation of a tissue-engineered tubular heart valve in growing lambs. Ann. Biomed. Eng. doi:10.1007/s10439-016-1605-7 (2016) (Epub ahead of print).
Lanuti P, Serafini F, Pierdomenico L et al. Human mesenchymal stem cells reendothelialize porcine heart valve scaffolds: novel perspectives in heart valve tissue engineering. Biores. Open Access 4, 288-297 (2015).
Tweddell JS. Advances in neonatal cardiac surgery: recent advances, the low-hanging fruit, what is on the horizon and the next moonshot. Curr. Opin. Cardiol. 31, 109-116 (2016).
Files MD, Boucek RJ. 'Shovel-Ready' applications of stem cell advances for pediatric heart disease. Curr. Opin. Pediatr. 24, 577-583 (2012).
Sizarov A, Boudjemline Y. Novel materials and devices in the transcatheter management of congenital heart diseases - the future comes slowly (part 1). Arch. Cardiovasc. Dis. 109, 278-285 (2016).
Sigler M, Jux C. Biocompatibility of septal defect closure devices. Heart 93, 444-449 (2007).
Van Dijck I, Budts W, Cools B et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart 101, 788-793 (2015).
Kong X, Grabitz RG, van Oeveren W et al. Effect of biologically active coating on biocompatibility of Nitinol devices designed for the closure of intra-atrial communications. Biomaterials 23, 1775-1783 (2002).
Heying R, Wolf C, Beekhuizen H et al. Fibrin- and collagen-based matrices attenuate inflammatory and procoagulant responses in human endothelial cell cultures exposed to Staphylococcus aureus. Tissue Eng. Part A 18, 147-156 (2012).
Ugaki S, Ishino K, Osaki S et al. Efficacy of a miniature centrifugal rotary pump (TinyPump) for transfusion-free cardiopulmonary bypass in neonatal piglets. ASAIO J. 53, 675-679 (2007).
Arens J, Schnoring H, Reisch F et al. Development of a miniaturized heart-lung machine for neonates with congenital heart defect. ASAIO J. 54, 509-513 (2008).
Shiose A, Takaseya T, Kim HI et al. In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells. ASAIO J. 57, 395-398 (2011).
Farooqi KM, Nielsen JC, Uppu SC et al. Use of 3-dimensional printing to demonstrate complex intracardiac relationships in double-outlet right ventricle for surgical planning. Circ. Cardiovasc. Imaging 8, doi:10.1161/CIRCIMAGING.114.003043 (2015).